mRNA |
BRD9876:MK-1775 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
0.06 |
mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.06 |
0.07 |
mRNA |
AZD6482 |
CTRPv2 |
pan-cancer |
AAC |
-0.065 |
0.07 |
mRNA |
quizartinib |
CTRPv2 |
pan-cancer |
AAC |
-0.065 |
0.07 |
mRNA |
lenvatinib |
CTRPv2 |
pan-cancer |
AAC |
-0.064 |
0.07 |
mRNA |
ABT-199 |
CTRPv2 |
pan-cancer |
AAC |
-0.076 |
0.07 |
mRNA |
Mdivi-1 |
CTRPv2 |
pan-cancer |
AAC |
0.063 |
0.07 |
mRNA |
decitabine |
CTRPv2 |
pan-cancer |
AAC |
-0.047 |
0.08 |
mRNA |
KIN001-102 |
GDSC1000 |
pan-cancer |
AAC |
0.052 |
0.08 |
mRNA |
BRD-K04800985 |
CTRPv2 |
pan-cancer |
AAC |
0.064 |
0.08 |